L’Extase totale : Le IIIe Reich, les Allemands et la drogue Norman Ohler La Découverte, 2018, 283 p. La Cliothèque, Jennifer Ghislain, Pierre-Yves Marzin | 3 Nov 2018 https://clio-cr.clionautes.org/lextase-totale-le-iiie-reich-les-allemands-et-la-drogue.html Norman Ohler est un journaliste et réalisateur de documentaires allemand. Il découvre les documents laissés par Théo Morell, médecin personnel d’Hitler, documents dans lesquels il évoque un Patient A qui subit « des injections quotidiennes, des substances douteuses, des doses croissantes ». C’est le point de départ de son enquête. Pervitine, la drogue du IIIe Reich Malgré une politique anti-drogues, la pervitine, à base de méthamphétamine, devient un médicament grand public. Délivrée librement, puis sous ordonnance à partir de 1939, [...]
Lire la suiteWhat Can We Learn About Schizophrenia From Studying the Human Model, Drug-Induced Psychosis ? Robin M. Murray, Alessandra Paparelli, Paul D. Morrison, Arianna Marconi, and Marta Di Forti American Journal of Medical Genetics, Part B, 2013, 162B, 661–670. Doi : 10.1002/ajmg.b.32177 When drug-induced psychoses were first identified in the mid- 20th century, schizophrenia was considered a discrete disease with a likely genetic cause. Consequently, drug-induced psychoses were not considered central to understanding schizophrenia as they were thought to be phenocopies rather than examples of the illness secondary to a particular known cause. However, now that we know that schizophrenia is a clinical syndrome with [...]
Lire la suitePersisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic psychedelic Use : An Online Survey Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths and Matthew W. Johnson Frontiers in Psychiatry, 2020, Vol 10, Article 955. Doi : 10.3389/fpsyt.2019.00955 Background : Observational data and preliminary studies suggest serotonin 2A agonist psychedelics may hold potential in treating a variety of substance use disorders (SUDs), including opioid use disorder (OUD). Aims : The study aim was to describe and analyze self-reported cases in which naturalistic psychedelic use was followed by cessation or reduction in other substance use. Methods : An anonymous online survey of [...]
Lire la suiteLegal highs : staying on top of the flood of novel psychoactive substances David Baumeister, Luis M. Tojo and Derek K. Tracy Therapeutic Advances in Psychopharmacology, 2015, Vol. 5, (2), 97–132 DOI: 10.1177/2045125314559539 Abstract : There has been growing clinical, public, and media awareness and concern about the availability and potential harmfulness of so-called ‘legal highs’, which are more appropriately called new or novel psychoactive substances (NPS). A cat-and-mouse process has emerged wherein unknown chemists and laboratories are producing new, and as yet nonproscribed, compounds for human consumption; and as soon as they are banned, which they inevitably are, slightly modified analogues are produced to [...]
Lire la suite